dabrafenib mesylate
View Patient InformationThe mesylate salt form of dabrafenib, an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene. B-raf belongs to the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which may be constitutively activated due to BRAF gene mutations.
Synonym: | dabrafenib methanesulfonate GSK2118436 methane sulfonate salt GSK2118436B |
---|---|
US brand name: | Tafinlar |